Skip to content
    Novalis LifeSciences logo

    Novalis LifeSciences

    Portsmouth, United StatesFounded 2017

    Novalis LifeSciences is a boutique investment and advisory firm for the life sciences industry, founded in 2017 by Marijn E. Dekkers. The firm invests in small to medium-size life science companies across life science tools, diagnostics, and biopharma therapeutics.

    70% of their portfolio is in Biotech & Life Sciences. They made 1 investment in the last 12 months. Average disclosed round size is $56.7M (across 19 rounds with reported amounts).

    Find people at Novalis LifeSciences on Goldilocks AI

    Portfolio

    17

    Fund Size

    $300M

    Top Stage

    Series B

    Last 12 Mo

    1

    Team

    Devin Leake

    Devin Leake

    Managing Director

    Paul Meister

    Paul Meister

    Partner

    CM

    Christel Morley

    Business Operations Manager

    Constantine G. (Dino) Pantelis

    Constantine G. (Dino) Pantelis

    COO

    Marijn Dekkers

    Marijn Dekkers

    Chairman

    MM

    Michael McGuire

    Accounting Manager

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    23 investments
    CompanyRoundAmountDate
    Flywheel logoFlywheelSeries B$27.5MDec 2025
    BlueWhale Bio logoBlueWhale BioSeed$18MSep 2023
    MMercy BioSeries A$41MApr 2023
    Mercy BioAnalytics logoMercy BioAnalyticsSeries A$41MApr 2023
    eTheRNA Immunotherapies logoeTheRNA ImmunotherapiesUnknown—Aug 2022
    eTheRNA logoeTheRNAUnknown—Aug 2022
    Enko logoEnkoSeries C$70MJul 2022
    Vizgen logoVizgenSeries C$85.2MJun 2022
    Sherlock Biosciences logoSherlock BiosciencesSeries B$80MMar 2022
    Ori Biotech logoOri BiotechSeries B$100MJan 2022
    Animol Discovery logoAnimol DiscoverySeries B$34MJan 2022
    AgBiome logoAgBiomeSeries D$116MSep 2021
    Vizgen logoVizgenSeries B$37MApr 2021
    AgBiome logoAgBiomeSeries D$116MJan 2021
    Enko logoEnkoSeries B$45MJun 2020
    eTheRNA logoeTheRNASeries B—Jun 2020
    Allurion logoAllurionGrowth$34MJan 2020
    BIOTALYS NV logoBIOTALYS NVSeries C—Jan 2019
    Allurion logoAllurionSeries C$27MJul 2017
    Sherlock logoSherlockSeries B$80M—
    Telesis Bio logoTelesis BioUnknown$21M—
    LevitasBio logoLevitasBioSeries C$70M—
    Allurion logoAllurionGrowth$34M—

    Top Co-Investors

    Last updated: 7 October 2026